ALK confirms top-line growth – bottom line remains unchanged
The allergy company guides for organic revenue growth of 7–11% in local currencies.
by marketwire, translated by kristoffer grønbæk
Danish allergy company ALK exits the first quarter showing top-line progress and a bottom line that is identical with the equivalent quarter last year.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
